FI63751B - Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat - Google Patents
Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat Download PDFInfo
- Publication number
- FI63751B FI63751B FI762258A FI762258A FI63751B FI 63751 B FI63751 B FI 63751B FI 762258 A FI762258 A FI 762258A FI 762258 A FI762258 A FI 762258A FI 63751 B FI63751 B FI 63751B
- Authority
- FI
- Finland
- Prior art keywords
- compounds
- formula
- tert
- butylaminopropoxy
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (4)
1. Analogiförfarande för framställning av nya terapeutiskt användbara 4-(3-tert-butylaminopropoxi)-2-metylindolderivat med formeln I, O-CORj^ o-ch2-ch-ch2~nh-c(ch3)3 UTXR5 H 3 väri R^ betecknar en fenylgrupp, som eventuellt är monosubstituerad med fluor, klor eller metoxi, eller en sekudär 1-fenoxialkylgrupp, vars sekundära alkylrest innehäller 3-5 kolatomer och vars fenylring eventuellt är monosubstituerad med klor, och R3 betecknar väte eller metyl, och syraadditionssalter därav, kännetecknat därav, att man acylerar föreningar med formeln II, OH
0-CH2-CH-CH2-NH-C(CH3)3 - *3 11 [Γ j ιΓ ^«3 väri R3 har ovan angiven betydelse, och ora sä önskas överför de er-hällna föreningarna med formeln I tili deras syraadditionssalter.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1071475 | 1975-08-15 | ||
| CH1071475 | 1975-08-15 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI762258A FI762258A (sv) | 1977-02-16 |
| FI63751B true FI63751B (fi) | 1983-04-29 |
| FI63751C FI63751C (fi) | 1983-08-10 |
Family
ID=4366041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI762258A FI63751C (fi) | 1975-08-15 | 1976-08-06 | Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4434176A (sv) |
| JP (2) | JPS5223073A (sv) |
| AT (1) | AT363070B (sv) |
| AU (1) | AU505719B2 (sv) |
| BE (1) | BE845197R (sv) |
| CA (1) | CA1080720A (sv) |
| CY (1) | CY1225A (sv) |
| DE (1) | DE2635209C2 (sv) |
| DK (1) | DK152120C (sv) |
| ES (1) | ES450681A1 (sv) |
| FI (1) | FI63751C (sv) |
| FR (1) | FR2320743A2 (sv) |
| GB (2) | GB1575510A (sv) |
| HK (1) | HK35884A (sv) |
| IE (1) | IE43797B1 (sv) |
| IL (2) | IL50263A (sv) |
| KE (1) | KE3404A (sv) |
| MY (1) | MY8500135A (sv) |
| NL (2) | NL176362C (sv) |
| NO (1) | NO762735L (sv) |
| NZ (1) | NZ181764A (sv) |
| PH (1) | PH13356A (sv) |
| PT (1) | PT65477B (sv) |
| SE (1) | SE414633B (sv) |
| SG (1) | SG84883G (sv) |
| SU (1) | SU649313A3 (sv) |
| YU (1) | YU198876A (sv) |
| ZA (1) | ZA764883B (sv) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2830211A1 (de) * | 1977-07-21 | 1979-02-01 | Sandoz Ag | Substituierte indol-derivate, ihre herstellung und verwendung |
| JPS58106499A (ja) * | 1981-12-19 | 1983-06-24 | 株式会社東芝 | 燃料交換装置のクランプ解除機構 |
| NL8600137A (nl) * | 1985-02-05 | 1986-09-01 | Sandoz Ag | Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten. |
| US5174210A (en) * | 1990-04-27 | 1992-12-29 | Heidelberger Druckmaschinen Aktiengesellschaft | Preparation of the inking unit of a printing press for a change of printing job |
| WO1995020568A1 (en) * | 1994-01-28 | 1995-08-03 | Cal International Limited | Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
| WO2004106299A2 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| KR101329112B1 (ko) * | 2005-11-08 | 2013-11-14 | 랜박시 래보러터리스 리미티드 | (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법 |
| WO2008020314A2 (en) * | 2006-03-14 | 2008-02-21 | Ranbaxy Laboratories Limited | Statin stabilizing dosage formulations |
| MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH532040A (de) * | 1970-03-24 | 1972-12-31 | Sandoz Ag | Verfahren zur Herstellung neuer Indolderivate |
| US3751429A (en) * | 1970-03-24 | 1973-08-07 | Sandoz Ltd | 4-(3-amino-2-substituted propoxy)indole derivatives |
| SE375771B (sv) * | 1970-09-30 | 1975-04-28 | Sandoz Ag | |
| CH545783A (en) * | 1971-01-07 | 1974-02-15 | Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides | |
| CH545784A (en) * | 1971-01-07 | 1974-02-15 | Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles |
-
1976
- 1976-08-05 DE DE2635209A patent/DE2635209C2/de not_active Expired
- 1976-08-06 DK DK357576A patent/DK152120C/da not_active IP Right Cessation
- 1976-08-06 NO NO762735A patent/NO762735L/no unknown
- 1976-08-06 FI FI762258A patent/FI63751C/fi not_active IP Right Cessation
- 1976-08-06 SE SE7608865A patent/SE414633B/sv unknown
- 1976-08-11 NL NLAANVRAGE7608902,A patent/NL176362C/xx active Protection Beyond IP Right Term
- 1976-08-12 FR FR7624659A patent/FR2320743A2/fr active Granted
- 1976-08-12 YU YU01988/76A patent/YU198876A/xx unknown
- 1976-08-13 AU AU16841/76A patent/AU505719B2/en not_active Expired
- 1976-08-13 CA CA259,050A patent/CA1080720A/en not_active Expired
- 1976-08-13 ES ES450681A patent/ES450681A1/es not_active Expired
- 1976-08-13 IE IE1791/76A patent/IE43797B1/en not_active IP Right Cessation
- 1976-08-13 AT AT0602576A patent/AT363070B/de not_active IP Right Cessation
- 1976-08-13 NZ NZ181764A patent/NZ181764A/xx unknown
- 1976-08-13 GB GB13931/79A patent/GB1575510A/en not_active Expired
- 1976-08-13 CY CY1125A patent/CY1225A/xx unknown
- 1976-08-13 PT PT65477A patent/PT65477B/pt unknown
- 1976-08-13 ZA ZA00764883A patent/ZA764883B/xx unknown
- 1976-08-13 BE BE169821A patent/BE845197R/xx active
- 1976-08-13 IL IL50263A patent/IL50263A/xx unknown
- 1976-08-13 SU SU762388420A patent/SU649313A3/ru active
- 1976-08-13 PH PH18788A patent/PH13356A/en unknown
- 1976-08-13 GB GB33753/76A patent/GB1575509A/en not_active Expired
- 1976-08-14 JP JP51096629A patent/JPS5223073A/ja active Granted
-
1979
- 1979-09-03 IL IL58163A patent/IL58163A0/xx unknown
-
1980
- 1980-05-23 JP JP6800480A patent/JPS5649318A/ja active Pending
-
1982
- 1982-05-06 US US06/375,369 patent/US4434176A/en not_active Expired - Lifetime
-
1983
- 1983-12-29 SG SG848/83A patent/SG84883G/en unknown
-
1984
- 1984-04-19 KE KE3404A patent/KE3404A/xx unknown
- 1984-04-26 HK HK358/84A patent/HK35884A/xx unknown
-
1985
- 1985-12-30 MY MY135/85A patent/MY8500135A/xx unknown
-
1993
- 1993-07-02 NL NL930134C patent/NL930134I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4288299B2 (ja) | Ｌｔｂ４−アンタゴニスト活性を有するベンズアミジン誘導体及びその医薬としての使用 | |
| KR870000741B1 (ko) | 벤젠설폰 아미도 유도체의 제조 방법 | |
| JPS6354321A (ja) | 血糖降下剤 | |
| CH639653A5 (fr) | Aminothiazoles et composition pharmaceutique les contenant. | |
| CA1213280A (fr) | PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DE 4-(1H- INDOL-3-YL) .alpha.-METHYL PIPERIDINE-1-ETHANOL ET DE LEURS SELS | |
| JPS62167752A (ja) | フエニルアセトニトリル誘導体その医薬組成物および哺乳動物におけるカルシウムイオンきつ抗作用または抗高圧作用促進方法 | |
| FI63751B (fi) | Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat | |
| EP0022118A1 (fr) | Nouveaux dérivés de sulfonyl-aniline, leur procédé de préparation et leur application en thérapeutique | |
| FI84057C (sv) | Förfarande för framställning av terapeutiskt aktiva fluorallylaminderi vat | |
| KR100352899B1 (ko) | 새로운3-페닐설포닐-3,7-디아자바이사이클로[3,3,1]노난-화합물을함유하는약제 | |
| EP0364350B1 (fr) | Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant | |
| Erhardt et al. | Ultra-short-acting. beta.-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy) propanolamines having esters on the aryl function | |
| EP0143016B1 (fr) | Dérivés de 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phényl acétamide, leur préparation et leur application en thérapeutique | |
| FR2510571A1 (fr) | Spirothiazolidinedione, son procede de production et preparation pharmaceutique la contenant | |
| EP0138684A2 (fr) | 2-(N-pyrrolidino)-3-isobutoxy-N-phenyl substitué N-benzyl propylamines, leur préparation et leur application pharmaceutique | |
| JPS6270335A (ja) | ２環性アリルエ−テル誘導体、その製法および用途 | |
| EP0168245A2 (en) | Basic oxime ethers, pharmaceutical compositions possessing antianginal activityand the use of basic oxime ethers for manufactoring medicaments for the treatment of angina | |
| US4100280A (en) | 1,3-Dialkyl-6,7-methoxy-1H-1,2,4-benzothiadiazine-1-oxides | |
| EP0347305B1 (fr) | [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif | |
| JPH0327367A (ja) | 新規な２―アミノ―５―アリールオキシメチルオキサゾリンとその塩 | |
| EP0031771B1 (fr) | Ethers de 1-(2-propynyloxy)-2-amino-3-propanol, leur préparation et une composition pharmaceutique les contenant | |
| RU2015964C1 (ru) | Способ получения замещенных производных амина | |
| US3976771A (en) | Glycylglycine amide preparations and method of use antiarrhythmic | |
| EP0275760B1 (fr) | Pipéridines, ou azépines substituées, leur préparation et leur application en thérapeutique | |
| JPH0351711B2 (sv) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired | ||
| MA | Patent expired |
Owner name: SANDOZ AG |